NSEOutcome of Board Meeting7h ago · 5 Sept 2026, 03:01 pm

Outcome of Board Meeting

Indo Us Biotech Limited · INDOUS

✦ AI SummaryMgmt Change

Indo Us Biotech Limited has informed the Exchange regarding Outcome of Board Meeting held on September 05, 2026, where the Board met and resolved various agendas including calling of Annual General Meeting, approved draft notice and directors' report, and appointment of statutory auditors.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Indo Us Biotech Limited has informed the Exchange regarding Outcome of Board Meeting held on September 05, 2026.

Attachments (1)

📄

INDOUS_05092026150103_Outcome_of_BM_05-09-2026.pdf

pdf

Download →
View document text
Date: 05th September, 2026 BSE Limited National Stock Exchange of India Limited Dept. of Corporate Services, Dept. of Corporate Compliances, Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1 Block-G, Dalal Street, Bandra Kurla Complex, Mumbai- 400 001 Bandra (E) Mumbai- 400 051 BSE Scrip Code - 541304 NSE Symbol: INDOUS Dear Sir / Mam, Sub.: Outcome of the Board Meeting held on Saturday, 05th September, 2026. The Board met today, discussed and resolved following agendas: 1) Calling of Annual General Meeting (AGM) on Wednesday, 30th Day of September, 2026 at 02:30 pm through video conferencing (VC)/other Audio-Visual Means (OAVM) for the financial year ended on 31st March, 2026. 2) Approved the draft notice for calling 22nd Annual General Meeting. 3) Approved the draft of Directors’ Report for the financial year ended on 31st March, 2026. 4) Book Closure Date for the 22nd Annual General Meeting for F.Y. 2025-26 (Details as Annex A) 5) The e-voting period shall commence from Sunday, 27th September, 2026, 9:00 AM to Tuesday, 29th September, 2026, 5:00 PM. The remote e-voting module shall be disabled by NSDL after 5.00 p.m. on Tuesday, 29th September, 2026.The cut-off for determining the eligibility to vote is 23rd September, 2026 and only the persons holding shares of the Company (in physical or dematerialised form) on the cut-off date shall be entitled to avail the facility of remote e-voting and electronic voting through electronic Method at the Annual General Meeting (AGM) held through VC/ OAVM on 30th September, 2026. 6) Annual Report to be circulated to the Members of the Company (being Uploaded as Separate Attachment / File) 7) Appointment of M/s. Bhagat & Associates, Chartered Accountants (FRN: 101100W) as a Statutory Auditors Of The Company for a period of five consecutive years from the conclusion of the ensuing 22nd Annual General Meeting until the conclusion of the 27th Annual General Meeting, subject to the approval of the Members at the ensuing Annual General Meeting. After due consideration, the Board approved and recommended the appointment of M/s. Bhagat & Associates as the Statutory Auditors of the Company for consideration and approval of the Members at the ensuing 22nd Annual General Meeting. 8) Appoint M/s. Amrish Gandhi & Associates, Practising Company Secretary scrutinizer to scrutinize the e- voting process in a fair and transparent manner for the Annual General Meeting of the Company for the financial year ended on 31st March, 2026. 9) Any other business with the permission of the Board Chair. The Meeting commenced at 14:10 Hrs and concluded at 14:40 Hrs. Do acknowledge the receipt of same and disseminate the above announcement on BSE’s and NSE’s Website. For Indo US Bio Tech Ltd. Ms. Dimpy Joshi Company Secretary & Compliance officer Annex A Security Type of Book Closure Date Code/NSE Security (both days inclusive) Purpose Symbol From To 541304/INDOUS Equity 23/09/2026 30/09/2026 To comply with the requirement of Regulation 42 of the SEBI (LODR) Regulation 2015 entered with your exchange. The books are closed for holding the Annual General Meeting on 30th September, 2026.